Hong-Jung Chen
Direttore/Membro del Consiglio presso APOLLOMICS, INC.
Profilo
Hong-Jung Chen is currently the Chairman & Chief Executive Officer at Maxpro Co., Ltd., the Managing Director at Maxpro Ventures Ltd., and the Independent Director at Apollomics, Inc. He previously served as the Chairman & Chief Executive Officer at Maxpro Capital Acquisition Corp., the Independent Director at Apollomics, Inc. (United States), and the Chief Operations Officer & Vice President at SyneuRx International (Taiwan) Corp.
From an educational standpoint, Dr. Chen holds doctorate degrees from the University of Medicine & Dentistry of New Jersey and Rutgers State University of New Jersey.
Posizioni attive di Hong-Jung Chen
Società | Posizione | Inizio |
---|---|---|
APOLLOMICS, INC. | Direttore/Membro del Consiglio | 30/03/2023 |
Maxpro Co., Ltd.
Maxpro Co., Ltd. Financial ConglomeratesFinance Maxpro Co., Ltd. operates as a technology company. It provides Forex market, financial, programming and automated-trading solutions. The company was founded on September 5, 2014 and is headquartered in Ho Chi Minh City, Vietnam. | Amministratore Delegato | 01/05/2018 |
Maxpro Ventures Ltd. | Corporate Officer/Principal | 01/05/2018 |
Precedenti posizioni note di Hong-Jung Chen
Società | Posizione | Fine |
---|---|---|
SYNEURX INTERNATIONAL (TAIWAN) CORP. | Direttore operativo | 01/01/2017 |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Direttore/Membro del Consiglio | - |
MAXO CAP | Amministratore Delegato | - |
Formazione di Hong-Jung Chen
Rutgers State University of New Jersey | Doctorate Degree |
University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
APOLLOMICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Maxpro Capital Acquisition Corp.
Maxpro Capital Acquisition Corp. Financial ConglomeratesFinance Maxpro Capital Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 2, 2021 and is headquartered in Taipei, Taiwan. | Finance |
SyneuRx International (Taiwan) Corp.
SyneuRx International (Taiwan) Corp. BiotechnologyHealth Technology SyneuRx International (Taiwan) Corp. engages in the manufacture and sale of medicines. It offers different kinds of medicines, which are useful for brain disorders like schizophrenia have largely failed to materialize and mental illnesses like depression, obsessive compulsive disorder, attention deficit hyperactivity disorder, autism and dementia. The company was founded by Kuo Chuan Tsai on April 2, 2013 and is headquartered in New Taipei, Taiwan. | Health Technology |
Maxpro Co., Ltd.
Maxpro Co., Ltd. Financial ConglomeratesFinance Maxpro Co., Ltd. operates as a technology company. It provides Forex market, financial, programming and automated-trading solutions. The company was founded on September 5, 2014 and is headquartered in Ho Chi Minh City, Vietnam. | Finance |
Maxpro Ventures Ltd. | |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
- Borsa valori
- Insiders
- Hong-Jung Chen